These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2140900)

  • 1. Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1990 May; 36(1):97-104. PubMed ID: 2140900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1990 Jun; 36(2):339-44. PubMed ID: 2141423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Br J Pharmacol; 1989 Feb; 96(2):325-32. PubMed ID: 2522335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.
    Higgins GA; Jones BJ; Oakley NR; Tyers MB
    Psychopharmacology (Berl); 1991; 104(4):545-51. PubMed ID: 1664112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behaviour in the rat.
    Herges S; Taylor DA
    Eur J Pharmacol; 1999 Jun; 374(3):329-40. PubMed ID: 10422777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse.
    Costall B; Kelly ME; Onaivi ES; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):547-51. PubMed ID: 2392157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands.
    Overstreet DH; Knapp DJ; Angel RA; Navarro M; Breese GR
    Psychopharmacology (Berl); 2006 Jul; 187(1):1-12. PubMed ID: 16767411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketotifen and its analogues reduce aversive responding in the rodent.
    Barnes NM; Costall B; Kelly ME; Onaivi ES; Naylor RJ
    Pharmacol Biochem Behav; 1990 Dec; 37(4):785-93. PubMed ID: 1965515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychopharmacology of 5-HT3 receptors.
    Costall B; Naylor RJ; Tyers MB
    Pharmacol Ther; 1990; 47(2):181-202. PubMed ID: 2203069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1998 Feb; 135(3):263-9. PubMed ID: 9498729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze.
    Vasar E; Peuranen E; Oöpik T; Harro J; Männistö PT
    Psychopharmacology (Berl); 1993; 110(1-2):213-8. PubMed ID: 7870888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron.
    Suzuki T; Ise Y; Mori T; Misawa M
    Life Sci; 1997; 61(16):PL249-54. PubMed ID: 9353175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat.
    Hillegaart V
    Physiol Behav; 1990 Jul; 48(1):143-8. PubMed ID: 2146690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol- and diazepam-withdrawal hyperlocomotion is not due to 5-HT3 receptor stimulation.
    Mehta AK; Ticku MK
    Pharmacol Biochem Behav; 1993 Jul; 45(3):755-7. PubMed ID: 8332636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.